Research

Report: 10 years of community-monitoring of ARV procurement in Russia

17 Aug 2020

News Research

ITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...

COVID-19 pandemic: ‘An opportunity of a lifetime’?

24 Apr 2020

News Research

The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...

Global headlines: Potential COVID-19 drugs are over-priced

23 Apr 2020

News Research

From the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...

Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.

10 Apr 2020

Call to action News Research

Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...

ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care

11 Jan 2020

News Research

ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care focused on barriers to quality HIV care...

Watch What Matters: Communities transforming healthcare

8 Nov 2019

News Research Video

When the Community Treatment Observatories (CTOs) were first set up in 11 countries in West Africa to monitor access to...

The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries

23 Sep 2019

News Opinion Research

A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...

The right to health is compulsory: Time for action on dolutegravir – now!

21 Jul 2019

Call to action News Research

Why Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...

Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices

10 Aug 2018

News Research

This new report by our partner I-MAK analyzes the twelve best selling drugs in the United States and shows how...

New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)

26 Oct 2017

News Research

ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...